跳至主要内容
临床试验/NCT05699551
NCT05699551撤回不适用

Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome

Wake Forest University Health Sciences0 个研究点目标入组 10 人开始时间: 2023年5月10日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
10
主要终点
Interstitial Cystitis Problem (ICPI) Index Scores

研究概览

简要总结

In this study, the efficacy of exercise to improve interstitial cystitis/bladder pain syndrome symptoms and quality of life will be investigated.

详细描述

Effective treatment for symptoms associated with interstitial cystitis/bladder pain syndrome is a significant clinical challenge due to the lack of insight into disease etiology/pathophysiology, costly and potentially invasive procedures, and a lack of research into potential therapeutics. The primary objective of this study is to determine if a supervised exercise program by a trained exercise physiologist can relieve pain and improve urinary and bladder symptoms in patients with interstitial cystitis/bladder pain syndrome. This has the potential to open enormous future avenues of research, save both patients and the healthcare system cost, and most importantly improve patients' lives. A second objective of this study is to determine if exercise alters depressive symptoms, often a comorbid diagnosis, in patients with interstitial cystitis/bladder pain syndrome. A third objective of this study is to examine urinary markers of inflammation before and after exercise in patients with interstitial cystitis/bladder pain syndrome.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult females (>18 years and <80 years) with a previously established clinical diagnosis of Interstitial cystitis/bladder pain syndrome (IC/BPS) will be eligible to participate
  • Must speak English
  • The clinical diagnosis of IC/BPS will be based on the recently published American Urological Association Guidelines definition: "An unpleasant sensation (pain, pressure, or discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms for more than six weeks duration, in the absence of infection or other identifiable causes"
  • The diagnosis will be confirmed by a urologist who specializes in the treatment of patients with IC/BPS

排除标准

  • Study participants must be fully ambulatory without the use of a cane, walker, or wheelchair
  • Study participants must be able to tolerate moderate aerobic exercise. It will also be required that a physician clear any subjects entering the exercise program who have signs and symptoms suggestive of cardiovascular, cerebrovascular, metabolic, or renal disease and have been active 3 days per week for 30 minutes each day
  • Any history of bladder cancer, uterine cancer, ovarian cancer, vaginal cancer, the current placement of a catheter, urethral diverticulum, spinal cord injury, stroke, Parkinson's disease, multiple sclerosis, spina bifida, cyclophosphamide treatment, radiation cystitis, bladder tuberculosis, or are experiencing an active genital herpes episode
  • Pregnant women are not eligible for this study

结局指标

主要结局

Interstitial Cystitis Problem (ICPI) Index Scores

时间窗: week 6

Participants answer a series of questions to get a final score. Scores range from 0-16, with 0 being no symptoms and 16 the most severe.

Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF) Scores

时间窗: week 6

This survey is used to grade people with chronic pelvic pain. Participants answer a series of questions. Scores range between 0 and 35, and studies have indicated that a score greater than 12 is indicative of significant symptoms

Interstitial Cystitis Symptom Index (ICSI) Scores

时间窗: week 3

Participants answer a series of questions to get a final score. Scores range from 0-20, with 0 being no symptoms and 20 the most severe.

次要结局

  • Changes in Composite Autonomic Symptom Score (COMPASS-31) Scores(baseline, week 3, week 6)
  • Change in the Short Form 36 (SF-36) Health Survey Scores(baseline, week 3, week 6)

研究者

申办方类型
Other
责任方
Sponsor

相似试验